Skip to main content
Terug
CTRE logo

CareTrust REIT, Inc.

Datakwaliteit: 100%
CTRE
NYSE Real Estate REIT - Healthcare Facilities
€ 37,59
▲ € 0,45 (1,21%)
Marktkapitalisatie: 7,27B
Dagbereik
€ 37,25 € 38,04
52-Weeksbereik
€ 25,82 € 41,72
Volume
1.897.234
50D / 200D Gem.
€ 38,74 / € 35,07
Vorige Slotkoers
€ 37,14

Quick Summary

Koershistorie

Financiële Trends

Sectorvergelijking

vs Real Estate sector mediaan (361 peers)

Metriek Aandeel Sector Mediaan
P/E 22,7 11,2
P/B 1,8 0,9
ROE % 9,2 6,1
Net Margin % 67,3 19,9
Rev Growth 5Y % 25,8 7,0
D/E 0,2 0,9

Koersdoel Analisten

Hold
€ 42,50 +13.1%
Low: € 40,00 High: € 44,00
Forward K/W
25,42
Forward WPA
€ 1,48
WPA Groei (sch.)
+0,0%
Omzet Sch.
481,83M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2029 € 1,69
€ 1,44 – € 1,87
785,10M 1
FY2028 € 1,67
€ 1,59 – € 1,74
691,94M 2
FY2027 € 1,58
€ 1,57 – € 1,61
544,86M 4

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-12 € 0,36 € 0,47 +32,1%
2025-11-05 € 0,47 € 0,45 -4,3%
2025-08-06 € 0,45 € 0,43 -4,4%
2025-05-01 € 0,43 € 0,42 -2,3%
2025-02-12 € 0,40 € 0,40 0,0%
2024-10-29 € 0,38 € 0,38 0,0%
2024-08-01 € 0,36 € 0,36 0,0%
2024-05-02 € 0,37 € 0,35 -5,4%

Dividend History

7 yr streak

Yield

0,04%

Payout Ratio

0,81%

Growth (3Y)

6,80%

Growth (5Y)

6,03%

Ex-Date Payment Date Amount Yield
Mar 31, 2026 Apr 15, 2026 € 0,39 3,71%
Dec 31, 2025 Jan 15, 2026 € 0,34 3,71%
Sep 30, 2025 Oct 15, 2025 € 0,34 3,73%
Jun 30, 2025 Jul 15, 2025 € 0,34 4,08%
Mar 31, 2025 Apr 15, 2025 € 0,34 4,22%
Dec 31, 2024 Jan 15, 2025 € 0,29 4,29%
Sep 30, 2024 Oct 15, 2024 € 0,29 3,73%
Jun 28, 2024 Jul 15, 2024 € 0,29 4,54%
Mar 27, 2024 Apr 15, 2024 € 0,29 4,67%
Dec 28, 2023 Jan 12, 2024 € 0,28 4,94%
Sep 28, 2023 Oct 13, 2023 € 0,28 5,44%
Jun 29, 2023 Jul 14, 2023 € 0,28 5,62%
Mar 30, 2023 Apr 14, 2023 € 0,28 5,77%
Dec 29, 2022 Jan 13, 2023 € 0,28 5,89%
Sep 29, 2022 Oct 14, 2022 € 0,28 6,15%
Jun 29, 2022 Jul 15, 2022 € 0,28 5,77%
Mar 30, 2022 Apr 15, 2022 € 0,28 5,52%
Dec 30, 2021 Jan 15, 2022 € 0,27 4,65%
Sep 29, 2021 Oct 15, 2021 € 0,27 5,06%
Jun 29, 2021 Jul 15, 2021 € 0,27 4,43%

Belangrijkste Punten

Revenue grew 25,82% annually over 5 years — strong growth
Earnings grew 156,27% over the past year
Net margin of 67,26% shows strong profitability
Debt/Equity of 0,22 — conservative balance sheet
Generating 379,04M in free cash flow
PEG of 0,24 suggests growth is underpriced

Groei

Revenue Growth (5Y)
25,82%
Revenue (1Y)108,79%
Earnings (1Y)156,27%
FCF Growth (3Y)62,36%

Kwaliteit

Return on Equity
9,23%
ROIC4,87%
Net Margin67,26%
Op. Margin67,17%

Veiligheid

Debt / Equity
0,22
Current Ratio1,54
Interest Coverage7,32

Waardering

P/E Ratio
22,68
Forward P/E25,42
P/B Ratio1,80
EV/EBITDA24,88
Dividend Yield0,04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 108,79% Revenue Growth (3Y) 54,91%
Earnings Growth (1Y) 156,27% Earnings Growth (3Y) 144,24%
Revenue Growth (5Y) 25,82% Earnings Growth (5Y) 45,27%
Profitability
Revenue (TTM) 476,59M Net Income (TTM) 320,54M
ROE 9,23% ROA 6,23%
Gross Margin 59,13% Operating Margin 67,17%
Net Margin 67,26% Free Cash Flow (TTM) 379,04M
ROIC 4,87% FCF Growth (3Y) 62,36%
Safety
Debt / Equity 0,22 Current Ratio 1,54
Interest Coverage 7,32
Dividends
Dividend Yield 0,04% Payout Ratio 0,81%
Dividend Growth (3Y) 6,80% Dividend Growth (5Y) 6,03%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 22,68 Forward P/E 25,42
P/B Ratio 1,80 P/S Ratio 15,25
PEG Ratio 0,24 Forward PEG N/A
EV/EBITDA 24,88 Fwd EV/EBITDA 21,67
Forward P/S 15,08 Fwd Earnings Yield 3,93%
FCF Yield 5,21%
Market Cap 7,27B Enterprise Value 7,96B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 476,59M 228,26M 198,60M 187,51M 190,20M
Net Income 320,54M 125,08M 53,74M -7,51M 71,98M
EPS (Diluted) 1,57 0,80 0,50 0,44 0,50
Gross Profit 281,79M 214,71M 189,01M 178,13M 186,62M
Operating Income 320,14M 124,06M 116,00M 103,81M 104,41M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5,15B 3,44B 2,08B 1,62B 1,64B
Total Liabilities 1,09B 507,63M 666,12M 771,41M 725,09M
Shareholders' Equity 4,04B 2,91B 1,42B 849,37M 915,76M
Total Debt 894,22M 396,93M 595,60M 719,50M 673,40M
Cash & Equivalents 198,04M 213,82M 294,45M 13,18M 19,90M
Current Assets 300,60M 368,26M 309,85M 25,89M 27,15M
Current Liabilities 195,25M 110,71M 70,52M 176,91M 131,69M

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
#632 of 1052
40
#16 of 326
81

Recente Activiteit

Ingestapt Cash Flow Compounder
Mar 24, 2026
Ingestapt Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026